A narrative review on Epidermal Growth Factor (EGF) intralesional infiltrations for diabetic complex wounds: The rational of an innovative delivery route
Jorge Berlanga‐Acosta(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Ariana García‐Ojalvo(Centro de Ingeniería Genética y Biotecnología), Nora Ventosa-Rull(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Lidia Ferrer‐Tasies(Centre for Research on Ecology and Forestry Applications), Yssel Mendoza‐Marí(Western University of Health Sciences), Calixto Valdes-Perez(National Institute of Quality), Lisette Ponce de León Pérez(Hospital Oncológico Docente "Conrado Benítez García"), Osvaldo Reyes Acosta(Centro de Ingeniería Genética y Biotecnología), Jose Fernandez-Montequin(National Institute of Quality), Eduardo Martínez-Díaz, William Savigne-Gutiérrez, Héctor Santana-Milián(Centro de Ingeniería Genética y Biotecnología), Luis Herrera-Martínez(Centro de Ingeniería Genética y Biotecnología), Yanisbel Ortiz Peña(Centro de Ingeniería Genética y Biotecnología)
Cited by 2
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134